A federal court ruling cleared the way Tuesday for OxyContin maker Purdue Pharma's settlement of thousands of legal claims over the toll of opioids.
The 2nd U.S. Circuit Court of Appeals in New York reversed a 2021 ruling that found bankruptcy court judges did not have the authority to shield from civil lawsuits members of the Sackler family who own Purdue and who have not filed for bankruptcy protection themselves.
